Appendix 2A - Application for quotation of securities Appendix 2A - Application for quotation of securities 1 / 8 Announcement Summary Entity name ENTROPY NEURODYNAMICS LIMITED Announcement Type New announcement Date of this announcement Friday August 07, 2026 The +securities to be quoted...
Application for quotation of securities - ENP
Filed with ASX ·
6ix hasn’t read this filing yet.
Entropy Neurodynamics Limited on 6ix
In the deck
Earlier from Entropy Neurodynamics
- BioShares 2026 Investor Presentation Deck
- 72 patient multi-indication trial approved to fast track TRP-8803 commercialisation
- 72-Patient Trial Fast-Tracks TRP-8803 Commercialisation
- Trading Halt
- South Africa Grants ENP Broad Fibromyalgia Patent to 2043
Later from Entropy Neurodynamics
- Cleansing Notice
- Change of Director's Interest Notice - HJ
- TRP 8803 manufacturing secured for Phase 2/3 advancement
- Entropy Advances TRP-8803 to US Phase 2 in Depression
- Appendix 4G and Corporate Governance Statement
Follow Entropy Neurodynamics into a list and get an email when it puts out news.
Follow Entropy Neurodynamics